Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China

References

• Saxena R, Mishra DK, Kashyap R, et al. Acquired haemophilia – a study of ten cases. Haemophilia. 2000;6:78–83. doi: 10.1046/j.1365-2516.2000.00372.x
   PubMed Web of Science ®Google Scholar
• Tiede A, Worster A. Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia. Ann Hematol. 2018;97:1889–1901. doi: 10.1007/s00277-018-3372-z
   PubMed Web of Science ®Google Scholar
• Collins P, Baudo F, Huth-Kuhne A, et al. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes. 2010;3:161. doi: 10.1186/1756-0500-3-161
   PubMedGoogle Scholar
• Zeitler H, Ulrich-Merzenich G, Goldmann G, et al. The relevance of the bleeding severity in the treatment of acquired haemophilia – an update of a single-centre experience with 67 patients. Haemophilia. 2010;16:95–101. doi: 10.1111/j.1365-2516.2008.01922.x
   PubMed Web of Science ®Google Scholar
• Jayakar JP, O'Neill N, Yan M, et al. Retrospective review of acquired haemophilia A from the largest Canadian haemophilia treatment centre. Haemophilia. 2018;24:e383–e387. doi: 10.1111/hae.13598
   PubMed Web of Science ®Google Scholar
• Kessler CM, Knobl P. Acquired haemophilia: an overview for clinical practice. Eur J Haematol. 2015;95(Suppl 81):36–44. doi: 10.1111/ejh.12689
   PubMed Web of Science ®Google Scholar
• Kose M, Bakkaloglu OK, Amikishiyev S, et al. Acquired FVIII and FIX inhibitors after pregnancy: a case report. Acta Haematol. 2016;136:229–232. doi: 10.1159/000445706
   PubMed Web of Science ®Google Scholar
• Rivera Cora NI, Irizarry Delgado F, Merle Ramirez SM, et al. Acquired hemophilia A in an advanced age patient of Hispanic origin: a case report. BMC Res Notes. 2017;10:438. doi: 10.1186/s13104-017-2767-6
   PubMedGoogle Scholar
• Takeyama M, Nogami K, Kajimoto T, et al. First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin. Int J Hematol. 2018;107:112–116. doi: 10.1007/s12185-017-2273-6
   PubMed Web of Science ®Google Scholar
• Napolitano M, Siragusa S, Mancuso S, et al. Acquired haemophilia in cancer: a systematic and critical literature review. Haemophilia. 2018;24:43–56. doi: 10.1111/hae.13355
   PubMed Web of Science ®Google Scholar
• Yang Y, Xue F, Shi H, et al. Acquired hemophilia A: retrospective analysis of 49 cases from a single Chinese hemophilia center. Clin Appl Thromb Hemost. 2015;21:35–40. doi: 10.1177/1076029613488937
   PubMed Web of Science ®Google Scholar
• Charlebois J, Rivard GE, St-Louis J. Management of acquired hemophilia A: review of current evidence. Transfus Apher Sci. 2018;57:717–720. doi: 10.1016/j.transci.2018.10.011
   PubMed Web of Science ®Google Scholar
• Knoebl P, Marco P, Baudo F, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012;10:622–631. doi: 10.1111/j.1538-7836.2012.04654.x
   PubMed Web of Science ®Google Scholar
• Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges. Semin Thromb Hemost. 2014;40:803–811. doi: 10.1055/s-0034-1390004
   PubMed Web of Science ®Google Scholar
• Kruse-Jarres R, Kempton CL, Baudo F, et al. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol. 2017;92:695–705. doi: 10.1002/ajh.24777
   PubMed Web of Science ®Google Scholar
• Kahle J, Orlowski A, Stichel D, et al. Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A. Blood. 2017;130:808–816. doi: 10.1182/blood-2016-11-751347
   PubMed Web of Science ®Google Scholar
• Wang XF, Zhao YQ, Yang RC, et al. The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A. Haemophilia. 2010;16:632–639.
   PubMed Web of Science ®Google Scholar
• Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood. 2007;109:1870–1877. doi: 10.1182/blood-2006-06-029850
   PubMed Web of Science ®Google Scholar
• Kessler CM, Ma AD, Al-Mondhiry HA, et al. Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry. Blood Coagul Fibrinolysis. 2016;27:761–769. doi: 10.1097/MBC.0000000000000582
   PubMed Web of Science ®Google Scholar
• Knobl P. Prevention and management of bleeding episodes in patients with acquired hemophilia A. Drugs. 2018;78:1861–1872. doi: 10.1007/s40265-018-1027-y
   PubMed Web of Science ®Google Scholar
• Ma AD, Kessler CM, Al-Mondhiry HA, et al. Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study. Blood Coagul Fibrinolysis. 2016;27:753–760. doi: 10.1097/MBC.0000000000000471
   PubMed Web of Science ®Google Scholar
• Zanon E, Pasca S, Siragusa S, et al. Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: data from the FAIR registry. Thromb Res. 2018;174:24–26. doi: 10.1016/j.thromres.2018.12.006
   PubMed Web of Science ®Google Scholar
• Zanon E, Milan M, Gamba G, et al. Activated prothrombin complex concentrate (FEIBA(R)) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study. Thromb Res. 2015;136:1299–1302. doi: 10.1016/j.thromres.2015.10.032
   PubMed Web of Science ®Google Scholar
• Arokszallasi A, Razso K, Ilonczai P, et al. A decade-long clinical experience on the prophylactic use of activated prothrombin complex concentrate in acquired haemophilia A: a case series from a tertiary care centre. Blood Coagul Fibrinolysis. 2018;29:282–287.
   PubMed Web of Science ®Google Scholar
• Franchini M, Vaglio S, Marano G, et al. Acquired hemophilia A: a review of recent data and new therapeutic options. Hematology. 2017;22:514–520. doi: 10.1080/10245332.2017.1319115
   PubMed Web of Science ®Google Scholar
• Elezovic I. Acquired haemophilia syndrome: pathophysiology and therapy. Srp Arh Celok Lek. 2010;138(Suppl 1):64–68. doi: 10.2298/SARH10S1064E
   PubMed Web of Science ®Google Scholar
• Vautier M, de Boysson H, Creveuil C, et al. Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center study. Medicine (Baltimore. 2016;95:e5232. doi: 10.1097/MD.0000000000005232
   PubMed Web of Science ®Google Scholar
• Tiede A, Klamroth R, Scharf RE, et al. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study. Blood. 2015;125:1091–1097. doi: 10.1182/blood-2014-07-587089
   PubMed Web of Science ®Google Scholar